Pilot Assessment of Lopinavir/Ritonavir and Maraviroc
Status:
Terminated
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
This is a study to assess the response of lopinavir/ritonavir plus maraviroc (with no
nucleoside medications) in HIV patients failing their initial antiviral therapy.